Neogen Chemicals (NEOGEN) Fundamentals 2026 — P/E 193.3x, Revenue Analysis | SniperIQ
Neogen Chemicals (NEOGEN) is a India-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ₹5,552 Crore, trading at ₹2113.60 on the BSE. This SniperIQ fundamentals page covers Neogen Chemicals's valuation (P/E 193.3x, P/B 6.8x), profitability (net margin 3.3%), revenue (₹862 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Neogen Chemicals's market cap?
Neogen Chemicals (NEOGEN) has a market capitalization of approximately ₹5,552 Crore, trading at ₹2113.60 on the BSE. Market cap moves with the live share price.
What is Neogen Chemicals's P/E ratio?
Neogen Chemicals's trailing twelve-month P/E ratio is 193.3x, with a price-to-book (P/B) of 6.8x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Neogen Chemicals?
Neogen Chemicals runs a net profit margin of 3.3%, a gross margin of 42.7%, and an operating margin of 12.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Neogen Chemicals generate?
Neogen Chemicals reported revenue of ₹862 Crore for fiscal year 2026, with net income of ₹29 Crore and earnings per share (EPS) of 10.9. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Neogen Chemicals pay a dividend?
Neogen Chemicals offers a trailing dividend yield of about 0.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Neogen Chemicals financially healthy?
Neogen Chemicals carries a debt-to-equity ratio of 1.71x and a current ratio of 1.17x, with a market beta of 0.60. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Neogen Chemicals a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Neogen Chemicals (NEOGEN) the key facts are: market cap ₹5,552 Crore, P/E 193.3x, revenue ₹862 Crore, 52-week range 978-2370. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Neogen Chemicals's full fundamentals live
Get Neogen Chemicals's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.